Write your message
Volume 10, Issue 4 (July-August 2016)                   IJT 2016, 10(4): 21-24 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Keramati M R, Sadeghian M H, Ayatollahi H, Basharati M H, Jalili M, Balali Mood M. Evaluation of JAK2 (V617F) Mutation in Iranian Veterans with Delayed Complications of Sulphur Mustard Poisoning. IJT 2016; 10 (4) :21-24
URL: http://ijt.arakmu.ac.ir/article-1-485-en.html
1- PhD of Hematopathology, Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
2- PhD of Hematopathology, Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. , Ayatollahih@mums.ac.ir
3- MD, Mashhad University of Medical Sciences, Mashhad, Iran.
4- BSc of Laboratory Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
5- Department of Toxicology, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:   (4347 Views)

Background: Sulfur mustard was the most widely applied chemical warfare agent by the Iraqi army in Iran–Iraq war (1983-1988). Considering the role of sulfur mustard toxicity in hematopoietic neoplasms and also new role of JAK2 mutation in these neoplasms, we assessed this mutation and delayed hematologic complications in veterans exposed to sulfur mustard.

Methods: This case control study was performed in Mashhad University of Medical Sciences, Mashhad, Iran in collaboration with Janbasan Foundation of Khorasan Razavi, Iran in 2012. The case group consists of 42 patients who exposed to sulfur mustard about 30 yr ago and the control group includes 30 healthy persons. For all subjects complete blood counts and ARMSpolymerase chain reaction for JAK2 (V617F) mutation was carried out. Data were analyzed by statistical software using independent sample t-testand Mann- Whitney U test.

Results: JAK2 (V617F) mutation was detected, neither in the sulfur mustardveterans nor in the control group.  Moreover no significant difference was detected in hematologic parameters between the two groups.

Conclusion: Despite sulfur mustard can increase risk of tumor genesis especially hematologic neoplasms but this is probablyas result of other genetic mechanism apart from JAK2 mutation. Considering the health and importance of preventive measure for the sulfur mustard victims, we suggest other genetic aspects of tumor genesis to be assessed in these patients.

Full-Text [PDF 92 kb]   (1500 Downloads)    
Type of Study: Research | Subject: Special

1. Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 2005;5(9):1479-85. Epub 2005/06/15. [DOI:10.1016/j.intimp.2005.04.003]
2. Keyhani A, Eslami MB, Razavimanesh H. The short-term effect of mustard gas on the serum immunoglobulin levels. Iran J Allergy Asthma Immunol 2007;6(1):15-9. Epub 2007/02/17.
3. Mansour Razavi S, Salamati P, Saghafinia M, Abdollahi M. A review on delayed toxic effects of sulfur mustard in Iranian veterans. DARU. J Pharma Sci 2012;20(1). DOI: 10.1186/2008-2231-20-51. [DOI:10.1186/2008-2231-20-51]
4. Zojaji R, Balali-Mood M, Mirzadeh M, Saffari A, Maleki M. Delayed head and neck complications of sulphur mustard poisoning in Iranian veterans. J Laryngol Otol 2009;123(10):1150-4. Epub 2009/07/04. [DOI:10.1017/S0022215109990260]
5. Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol 2006;5(3):101-8. Epub 2007/01/24.
6. Namazi S, Niknahad H, Razmkhah H. Long-term complications of sulphur mustard poisoning in intoxicated Iranian veterans. J Med Toxicol 2009;5(4):191-5. Epub 2009/10/31. [DOI:10.1007/BF03178265]
7. Shams J, Ghazanfari T, Yaraee R, Mahdavi MRV, Soroush MR, Hassan ZM, et al. Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Rev 2009;28(1):39-43. [DOI:10.1080/15569540802689626]
8. Stricker TP, Kumar V. Neoplasia. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders Elsevier; 2010. p. 259-320. [DOI:10.1016/B978-1-4377-0792-2.50012-2]
9. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352(17):1779-90. Epub 2005/04/29. [DOI:10.1056/NEJMoa051113]
10. Jowsey PA, Williams FM, Blain PG. DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide. Toxicology 2009;257(3):105-12. [DOI:10.1016/j.tox.2008.12.001]
11. Michaelson S. DNA fragmentation pattern induced in thymocytes by sulphur mustard. Chem Biol Interact 2000;125(1):1-15. [DOI:10.1016/S0009-2797(99)00155-6]
12. Ray R, Simbulan-Rosenthal CM, Keyser BM, Benton B, Anderson D, Holmes W, et al. Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology 2010;271(3):94-9. Epub 2010/03/17. [DOI:10.1016/j.tox.2010.03.008]
13. Jowsey PA, Williams FM, Blain PG. DNA damage responses in cells exposed to sulphur mustard. Toxicol Lett 2012;209(1):1-10. Epub 2011/11/29. [DOI:10.1016/j.toxlet.2011.11.009]
14. Jowsey PA, Williams FM, Blain PG. The role of homologous recombination in the cellular response to sulphur mustard. Toxicol Let 2010;197(1):12-8. [DOI:10.1016/j.toxlet.2010.04.020]
15. Masta A, Gray PJ, Phillips DR. Effect of sulphur mustard on the initiation and elongation of transcription. Carcinogenesis 1996;17(3):525-32. [DOI:10.1093/carcin/17.3.525]
16. Ghanei M, Vosoghi AA. An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environ Health Perspect 2002;110(5):519-21. Epub 2002/05/11. [DOI:10.1289/ehp.02110519]
17. Meier C, Hoeller S, Bourgau C, Hirschmann P, Schwaller J, Went P, et al. Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas. Mod Pathol 2009;22(3):476-87. Epub 2009/01/13. [DOI:10.1038/modpathol.2008.207]
18. Quintas-Cardama A, Verstovsek S. Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res 2013;19(8):1933-40. Epub 2013/02/15. [DOI:10.1158/1078-0432.CCR-12-0284]
19. Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, Phillips LA, et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 2009;106(23):9414-8. Epub 2009/05/28. [DOI:10.1073/pnas.0811761106]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb